Literature DB >> 17613528

Tissue factor coagulant function is enhanced by protein-disulfide isomerase independent of oxidoreductase activity.

Henri H Versteeg1, Wolfram Ruf.   

Abstract

Protein-disulfide isomerase (PDI) switches tissue factor (TF) from coagulation to signaling by targeting the allosteric Cys186-Cys209 disulfide. Here, we further characterize the interaction of purified PDI with TF. We find that PDI enhances factor VIIa-dependent substrate factor X activation 5-10-fold in the presence of wild-type, oxidized soluble TF but not TF mutants that contain an unpaired Cys186 or Cys209. PDI-accelerated factor Xa generation was blocked by bacitracin but not influenced by inhibition of vicinal thiols, reduction of PDI, changes in redox gradients, or covalent thiol modification of reduced PDI by N-ethylmaleimide or methyl-methanethiosulfonate, which abolished PDI oxidoreductase but not chaperone activity. PDI had no effect on fully active TF on either negatively charged phospholipids or in activating detergent, indicating that PDI selectively acts upon cryptic TF to facilitate ternary complex formation and macromolecular substrate turnover. PDI activation was reduced upon mutation of TF residues in proximity to the macromolecular substrate binding site, consistent with a primary interaction of PDI with TF. PDI enhanced TF coagulant activity on microvesicles shed from cells, suggesting that PDI plays a role as an activating chaperone for circulating cryptic TF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613528     DOI: 10.1074/jbc.M702410200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Role of thiol pathways in TF procoagulant regulation.

Authors:  Wolfram Ruf
Journal:  Thromb Res       Date:  2012-03-07       Impact factor: 3.944

Review 2.  Decryption of tissue factor.

Authors:  Saulius Butenas; Jolanta Krudysz-Amblo
Journal:  Thromb Res       Date:  2012-03-07       Impact factor: 3.944

3.  Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated mice.

Authors:  James P Luyendyk; Kevin C Flanagan; C David Williams; Hartmut Jaeschke; Joyce G Slusser; Nigel Mackman; Glenn H Cantor
Journal:  Toxicol Appl Pharmacol       Date:  2010-11-09       Impact factor: 4.219

4.  Bovine protein disulfide isomerase-enhanced tissue factor coagulant function: is phospholipid contaminant in it the real culprit?

Authors:  Hema Kothari; Prosenjit Sen; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2008-03-15       Impact factor: 22.113

Review 5.  Vascular thiol isomerases.

Authors:  Robert Flaumenhaft; Bruce Furie
Journal:  Blood       Date:  2016-06-29       Impact factor: 22.113

Review 6.  The intersection of protein disulfide isomerase and cancer associated thrombosis.

Authors:  Jack D Stopa; Jeffrey I Zwicker
Journal:  Thromb Res       Date:  2018-04       Impact factor: 3.944

7.  Tracing the molecular pathogenesis of antiphospholipid syndrome.

Authors:  Hartmut Weiler
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 8.  Novel therapies targeting endometriosis.

Authors:  Hugh S Taylor; Kevin G Osteen; Kaylon L Bruner-Tran; Charles J Lockwood; Graciela Krikun; Anna Sokalska; Antoni J Duleba
Journal:  Reprod Sci       Date:  2011-06-21       Impact factor: 3.060

9.  Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.

Authors:  Chloe C Milsom; Joanne L Yu; Nigel Mackman; Johann Micallef; G Mark Anderson; Abhijit Guha; Janusz W Rak
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 10.  Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  World J Clin Oncol       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.